Possible long-term malaria protection on trial

Researchers at the Radboud university medical centre in Nijmegen have been running trials of a medicine that seems to give long-term protection against malaria, news agency ANP reports.

The medicine chloroquine, which had fallen into disuse, was given to test patients for three months. In the same period they were bitten by malaria-carrying mosquitoes. An immune response built up which was still working 2.5 years later, the researchers say.
Professor Robert Sauerwein, who is leading the research, says the tests provide a blueprint for the manufacture of an effective vaccine for the disease, which kills millions of people every year.

Thank you for donating to DutchNews.nl.

We could not provide the Dutch News service, and keep it free of charge, without the generous support of our readers. Your donations allow us to report on issues you tell us matter, and provide you with a summary of the most important Dutch news each day.

Make a donation